Indocyanine green use, detection and safety in patients with breast cancer undergoing sentinel lymph node biopsy: A French prospective observational study. (2026)

Peer-Reviewed Study · Koual M, Azaïs H, Marchal F, Kerbage Y, Tardif D, Postila V, Chauleur C · June 9, 2026

Koual M et al., 2026-06-09: French multicentre prospective observational study (OASIS) of indocyanine green for breast sentinel node biopsy reporting real-world effectiveness with no adverse events.

No adverse events or serious adverse events were reported.

Koual M et al., 2026-06-09: French multicentre prospective observational study (OASIS) of indocyanine green for breast sentinel node biopsy reporting real-world effectiveness with no adverse events. C7 (comparator context). Study type: prospective multicentre observational study; Paris Cite University, AP-HP Georges Pompidou European Hospital, France. N not stated in the abstract text captured. Records ICG as an alternative to colorimetric and radioactive tracers with high sensitivity and rare allergenicity; no methylene-blue-specific comparison in the abstract, hence PARTLY. Funder/conflicts not stated in the abstract. Surg Oncol 2026;67:102476. Study type: uncontrolled series.